2011 Sep-Oct;23(5):220-6 2
The Alabama AG alleges that patients at the health clinic thought they were receiving normal GLP-1 prescriptions such as Ozempic medication
Both are exploring the effects of targeting the GCGR for its impact on liver complications of obesity
Research also indicates that GLP-1 receptor agonists like semaglutide can help prevent the weight loss-associated decrease in free leptin production by adipose tissue and promote the synthesis of Peptide YY (3-36) by endocrine cells in the human small intestine, which may promote long-term appetite and body weight control [11]
Starting from a library of 9,000+ molecules, our pipeline combined virtual screening, QSAR modeling, ADME/toxicity profiling, and molecular dynamics simulations in on 10 highly promising COX-2 inhibitors, compounds with the selectivity, stability, and safety profile worth taking into the lab
17(12):e1003228 Doumouras AG, Hong D, Lee Y, Tarride JE, Paterson JM, Anvari M (2020) Association between bariatric surgery and all-cause mortality: a population-based matched cohort study in a universal health care system
